San Diego-based Halozyme Therapeutics has appointed Gerhard Baumgartner, MD to its Scientific Advisory Board. Professor Baumgartner is at the Ludwig Boltzmann Institute for Clinical Oncology in Vienna, Austria, and focuses on using bovine hyaluronidase enzymes to enhance the effectiveness of chemotherapy agents.